Vericel Corp. (VCEL)

[commoncentsinvestor]

Well, this guy seems to like VCEL:

$VCEL – Vericel Corp. Analysis

BY SALMAN AZIZ / SUNDAY, 19 FEBRUARY 2017 / PUBLISHED IN DAY TRADING
Vericel Corp. (VCEL: NASDAQ) formerly Aastrom Biosciences, Inc., is a commercial-stage biopharmaceutical company dedicated to the identification, development and commercialization of therapies that enable the body to repair and regenerate damaged tissues and organs to restore normal structure and function.

As of February 17, 2017, VCEL closed very strongly at $3.05 not only above the 50 day moving average, but also above major resistance of $3.00. The MACD is bullish crossover and remains above the 0 trend line. VCEL shares traded below the average volume, over 877k shares exchanging hands. In addition, VCEL had experienced a gradual rise in the RSI closing above to the 60 trend line, suggesting VCEL should continue to experience ongoing buyer’s interest and momentum.

A purchase price below $3.10 is an ideal entry position and could bring you returns of 15% to 20% in the next 30 days. If the stocks begins to experience some retracement, I would not recommend purchasing the stock if if drops below the $2.85 range.
If VCEL breaks out above $3.10, we could see it reaching the $3.40 plus levels within the next two weeks thereafter.

Be sure you place a stop loss at 10% below you buy price, and don’t be greedy, a consistent 10% to 15% per month can help dealing with losses and sometimes help bring in more profits.

Also, please keep in mind we are not offer trading advice, we are just sharing an idea.